Medical Marijuana - Medical, Legal, Social and Political Issues
You are not logged in. Only partial content from this topic will be available to you. To view the full content, you must log in to your account. Don't have a login? Register now. Or, check out our Preview.

The Medical Use of Cannabis and Cannabinoids in Inflammatory Bowel Disease by Professor Raphael Mechoulam and Dr. Timna Naftali

Gerich et al. recently summarized the data supporting the use of marijuana for digestive disorders (1). The authors' tentative positive attitude to clinical use  of marijuana is based on published evidence from patients with gastrointestinal disorders that self medicate with marijuana and on the clinical trials published so far. However, the authors emphasize that at present the clinical data is limited and hence 'clinical efficacy of marijuana or its constituent phytochemicals for digestive disorders remains unclear'. This module will review the rationale for the use of cannabis in the treatment of inflammatory bowel disease (IBD) and the available clinical evidence for the use of cannabis in treatment of IBD and associated symptoms.

Take a quiz or play a crossword related to this syllabus topic.

This syllabus content additionally qualifies for the following CME designations: Medical Marijuana, Pain Medicine, Palliative Care, Risk Management